Stoke Therapeutics Inc. (STOK)
NASDAQ: STOK
· Real-Time Price · USD
9.43
0.25 (2.72%)
At close: May 28, 2025, 3:59 PM
9.40
-0.32%
After-hours: May 28, 2025, 04:41 PM EDT
2.72% (1D)
| Bid | 9.05 |
| Market Cap | 514.85M |
| Revenue (ttm) | 190.91M |
| Net Income (ttm) | 50.27M |
| EPS (ttm) | 0.82 |
| PE Ratio (ttm) | 11.5 |
| Forward PE | -3.45 |
| Analyst | Buy |
| Ask | 9.82 |
| Volume | 362,844 |
| Avg. Volume (20D) | 844,351 |
| Open | 9.24 |
| Previous Close | 9.18 |
| Day's Range | 9.08 - 9.64 |
| 52-Week Range | 5.35 - 17.58 |
| Beta | 1.20 |
About STOK
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol STOK
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for STOK stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
+12.07%
Stoke Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
6 months ago
+1.53%
Stoke Therapeutics shares are trading higher on possible continued strength following Q3 reported financial results yesterday. Also, Needham and HC Wainwright & Co. reiterated Buy ratings on the stock.
